Rare homozygous nonsense variant in AIMP1 causing Early Onset Epileptic Encephalopathy with Burst Suppression (EOEE-BS)

Eur J Med Genet. 2020 Sep;63(9):103970. doi: 10.1016/j.ejmg.2020.103970. Epub 2020 Jun 10.

Abstract

Pathogenic variants in AIMP1 gene are rare causes of neurologic disorders. Homozygous frameshift and nonsense variants in AIMP1 have been described in severe neurodegenerative disease. This is the third report of a homozygous nonsense variant in AIMP1 [c.115 C > T (p.Gln39*)] in a girl with severe neonatal onset epileptic encephalopathy. Like the two other cases reported, our patient is also of Filipino descent. Clinical features include microcephaly, poor visual motor development, shallow breathing, severe hypertonia in extremities, severe global developmental delay, poor gag and suck reflex, failure to thrive in the neonatal period, and early onset intractable seizures. Brain MRI showed hypoplasia of corpus callosum as well as cerebellar vermis, global volume loss and diminished myelination for her age. Electroencephalogram at four months of age showed background consisting of synchronous and asynchronous intervals of burst suppression with intermittent multifocal spikes predominantly in the bi-temporal region, suggestive of Early Onset Epileptic Encephalopathy with Burst Suppression (EOEE-BS) which has not been previously associated with the c.115 C > T variant in AIMP1. Of note, she presented to us in super refractory status epilepticus which was eventually controlled after administration of ketogenic diet and Epidiolex (cannabidiol). This report expands the genetic landscape of EOEE-BS. This is the first case of this specific variant in which Epidiolex was administered, which along with Ketogenic diet aided in controlling patient's super refractory status epilepticus.

Keywords: AIMP1; EOEE-BS; Epileptic encephalopathy; Neurodegenerative diseases.

Publication types

  • Case Reports

MeSH terms

  • Anticonvulsants / therapeutic use
  • Brain / diagnostic imaging
  • Brain / physiopathology
  • Brain Waves*
  • Cannabidiol / therapeutic use
  • Codon, Nonsense*
  • Cytokines / genetics*
  • Developmental Disabilities / drug therapy
  • Developmental Disabilities / genetics*
  • Developmental Disabilities / pathology
  • Diet, Ketogenic
  • Epilepsy / drug therapy
  • Epilepsy / genetics*
  • Epilepsy / pathology
  • Female
  • Homozygote
  • Humans
  • Infant
  • Neoplasm Proteins / genetics*
  • RNA-Binding Proteins / genetics*

Substances

  • Anticonvulsants
  • Codon, Nonsense
  • Cytokines
  • Neoplasm Proteins
  • RNA-Binding Proteins
  • small inducible cytokine subfamily E, member 1
  • Cannabidiol